Addressing Human Papillomavirus Prevention During Pediatric Acute Sexual Assault Care
- PMID: 30130316
- PMCID: PMC6114142
- DOI: 10.1097/JFN.0000000000000209
Addressing Human Papillomavirus Prevention During Pediatric Acute Sexual Assault Care
Abstract
Background/objectives: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. Pediatric sexual assault (SA) victims are a special population eligible for HPV vaccination at the age of 9 years. National clinical practice guidelines advise clinicians to address HPV during emergency department (ED)-based SA care and at follow-up. At our institution, addressing HPV among suspected SA victims was highly variable, and HPV counseling was subsequently recommended on an ED-based acute SA clinical pathway as standard care. The aim of this study was to determine the proportion of age-eligible SA victims who received HPV counseling, determine victim characteristics associated with addressing HPV during SA care, and identify barriers to addressing HPV in the ED.
Methods: This study used a retrospective chart review of 448 pediatric SA victims presenting to the ED for acute postassault care.
Results: HPV was discussed in 10 of 56 (18%) and 37 of 49 (76%) cases in the control versus intervention groups, respectively. To verify vaccination status, caregiver recall was relied upon for 32 of 56 patients in the control group (57%) and 24 of 49 patients in the intervention group (48.9%). Factors associated with failure to discuss HPV during postassault care were younger age at encounter (OR = 0.78, 95% CI [0.67, 0.90], p < 0.001), verbal report of vaccination status verification (OR = 2.98, 95% CI [1.51, 6.01]), and male gender of the victim (OR = 3.35, 95% CI [1.20, 11.94]).
Conclusions: Significant barriers to addressing HPV in the ED setting exist, most significantly reliance on caregiver recall to guide vaccination administration, raising concern for overvaccination and undervaccination.
Conflict of interest statement
Similar articles
-
Centers for Disease Control and Prevention 2015 Human Papillomavirus Vaccine Recommendations for Sexually Assaulted Patients: A Review and Update.J Forensic Nurs. 2016 Oct/Dec;12(4):160-166. doi: 10.1097/JFN.0000000000000126. J Forensic Nurs. 2016. PMID: 27782923 Review.
-
Human Papilloma Virus Vaccination After Pediatric Sexual Abuse Evaluations in the Outpatient Child Sexual Abuse Subspecialty Clinic: A Quality Improvement Project.J Forensic Nurs. 2020 Jan/Mar;16(1):16-21. doi: 10.1097/JFN.0000000000000251. J Forensic Nurs. 2020. PMID: 31567656
-
Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children.Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S856-64. doi: 10.1093/cid/civ786. Clin Infect Dis. 2015. PMID: 26602623 Review.
-
Prophylaxis provided to sexual assault victims seen at US emergency departments.J Am Med Womens Assoc (1972). 2002 Fall;57(4):204-7. J Am Med Womens Assoc (1972). 2002. PMID: 12405238
-
Impact of sexual assault nurse examiners on the evaluation of sexual assault in a pediatric emergency department.Pediatr Emerg Care. 2008 Jul;24(7):442-7. doi: 10.1097/PEC.0b013e31817de11d. Pediatr Emerg Care. 2008. PMID: 18580706
Cited by
-
HPV vaccination programs in LMIC: is it time to optimize schedules and recommendations?J Pediatr (Rio J). 2023 Mar-Apr;99 Suppl 1(Suppl 1):S57-S61. doi: 10.1016/j.jped.2022.11.012. Epub 2023 Jan 10. J Pediatr (Rio J). 2023. PMID: 36638833 Free PMC article. Review.
-
Health care providers' responses to sexually abused children and adolescents: a systematic review.BMC Health Serv Res. 2022 Apr 4;22(1):441. doi: 10.1186/s12913-022-07814-9. BMC Health Serv Res. 2022. PMID: 35379242 Free PMC article.
-
A Scoping Review of Current Social Emergency Medicine Research.West J Emerg Med. 2021 Oct 27;22(6):1360-1368. doi: 10.5811/westjem.2021.4.51518. West J Emerg Med. 2021. PMID: 34787563 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention. Incidence, prevalence, and cost of sexually transmitted infections in the United States. 2013 Retrieved from https://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf.
-
- Centers for Disease Control and Prevention. Frequently asked questions about HPV vaccine safety (2017a) 2017a Retrieved from https://www.cdc.gov/vaccinesafety/vaccines/hpv/hpv-safety-faqs.html.
-
- Centers for Disease Control and Prevention. Genital HPV infection-fact sheet. 2017b Retrieved from https://www.cdc.gov/std/hpv/stdfact-hpv.htm.
-
- Centers for Disease Control and Prevention. Recommended immunization schedule for children and adolescents aged 18 years or younger. 2017c Retrieved from https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-com....
-
- Centers for Disease Control and Prevention. HPV Vaccination is Cancer Prevention for Boys Too (2016) 2016 Retrieved from https://www.cdc.gov/features/hpvvaccineboys/index.html.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical